Larson Financial Group’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-922
| Closed | -$751 | – | 1923 |
|
|
2023
Q3 | $751 | Hold |
922
| – | – | ﹤0.01% | 1532 |
|
|
2023
Q2 | $851 | Hold |
922
| – | – | ﹤0.01% | 1383 |
|
|
2023
Q1 | $699 | Hold |
922
| – | – | ﹤0.01% | 1384 |
|
|
2022
Q4 | $2.31K | Hold |
922
| – | – | ﹤0.01% | 1168 |
|
|
2022
Q3 | $1K | Hold |
922
| – | – | ﹤0.01% | 1272 |
|
|
2022
Q2 | $1K | Hold |
922
| – | – | ﹤0.01% | 1170 |
|
|
2022
Q1 | $3K | Hold |
922
| – | – | ﹤0.01% | 884 |
|
|
2021
Q4 | $2K | Hold |
922
| – | – | ﹤0.01% | 982 |
|
|
2021
Q3 | $2K | Hold |
922
| – | – | ﹤0.01% | 802 |
|
|
2021
Q2 | $3K | Hold |
922
| – | – | ﹤0.01% | 712 |
|
|
2021
Q1 | $3K | Hold |
922
| – | – | ﹤0.01% | 690 |
|
|
2020
Q4 | $2K | Buy |
+922
| New | +$2K | ﹤0.01% | 660 |
|